background


Product Information:

AGL 2043

AGL 2043 is an effective inhibitor of PDGFR (IC50=0.8 μM) and TEL-PDGFR kinases, as well as FLT3 and KIT kinases. AGL 2043 can effectively inhibit porcine cardiac smooth muscle cell proliferation and balloon-induced vascular stenosis, and is suitable for development as an anti-restenotic and anticancer agent[1].

Cat. No.: EX-A14869    Purity: >98%
Chemical
Chemical structure of AGL 2043


For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
100mgget quoteInquire
500mgget quoteInquire
1gget quote


CAS No.226717-28-8
Purity>98%
FormulaC15H12N4S
Mol Weight280.348
StoragePlease store the product under the recommended conditions in the Certificate of Analysis.
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  

[1]. Gazit A, et al. Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit. Bioorg Med Chem. 2003;11(9):2007-2018.

CoACoA of AGL 2043
Smiles:CC1=NC2=C(N1C)C=C3C(=C2)N=C(C=N3)C4=CC=CS4

KEYWORDS: buy AGL 2043 | AGL 2043 supplier | purchase | cost | manufacturer | order | distributor | buy 226717-28-8 | 226717-28-8 supplier